Literature DB >> 28440455

α-adrenoceptor-mediated enhanced inducibility of atrial fibrillation in a canine system inflammation model.

Ying-Ying Chen1, Ze-Wei Sun2, Jian-Ping Jiang3, Xiao-Dong Kang4, Lin-Lin Wang5, Yue-Liang Shen1, Xu-Dong Xie2, Liang-Rong Zheng2.   

Abstract

The exact mechanism associated with inflammation and atrial fibrillation (AF) remains unknown. The aim of the present study was to investigate the roles of connexin 43 (Cx43) and a1‑adrenergic receptor (α1‑AR) activation in the pathogenesis of system inflammation‑induced AF. A canine model of chronic low‑grade system inflammation was established by administrating a low dose of lipopolysaccharide (LPS; 0.1 µg/kg) for 2 weeks. Programmed stimulation was applied on the right atrial appendage to determine the effective refractory periods (ERP) and the window of vulnerability (WOV). Tumor necrosis factor α (TNF‑α) and interleukin 6 (IL‑6) levels in plasma and atrial tissue were measured by ELISA. Cx43, Toll‑like receptor 4 (TLR4) and nuclear factor κB (NF‑κB) proteins were analyzed using western blotting or immunohistochemistry. Administration of LPS for 2 weeks increased the concentration of TNF‑α and IL‑6 in the plasma and right atrium. ERP was markedly shortened and cumulative WOV was significantly widened in the LPS group. Following treatment with LPS, the amount of Cx43 protein in the area of intercalated disk increased. In addition, a high‑density of Cx43 in the lateral connection was identified. LPS also induced the activation of NF‑κB in the canine atrium. Administration with the α1‑AR blocker doxazosin prevented the production of LPS‑induced inflammatory cytokine and reversed the enhanced vulnerability to atrial fibrillation. Doxazosin inhibited the LPS‑induced increase in Cx43 protein and heterogeneous distribution, and prevented the activation of NF‑κB. These results indicated that chronic low‑grade system inflammation may increase the inducibility of AF in a canine model. The underlying mechanism may be involved in the LPS‑induced activation of NF‑κB, and the increase in Cx43 expression and lateral distribution via an α1-AR-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28440455     DOI: 10.3892/mmr.2017.6477

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

Review 1.  Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.

Authors:  Monika Gawałko; Thomas A Agbaedeng; Arnela Saljic; Dominik N Müller; Nicola Wilck; Renate Schnabel; John Penders; Michiel Rienstra; Isabelle van Gelder; Thomas Jespersen; Ulrich Schotten; Harry J G M Crijns; Jonathan M Kalman; Prashanthan Sanders; Stanley Nattel; Dobromir Dobrev; Dominik Linz
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

Review 2.  The role of the gut microbiota in health and cardiovascular diseases.

Authors:  Lu Wang; Shiqi Wang; Qing Zhang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Mol Biomed       Date:  2022-10-11

3.  Expression of Toll-Like Receptors in the Animal Model of Bladder Outlet Obstruction.

Authors:  Grzegorz Niemczyk; Lukasz Fus; Katarzyna Czarzasta; Anika Jesion; Piotr Radziszewski; Barbara Gornicka; Agnieszka Cudnoch-Jedrzejewska
Journal:  Biomed Res Int       Date:  2020-12-12       Impact factor: 3.411

4.  Muscarinic receptor regulation of chronic pain-induced atrial fibrillation.

Authors:  Chao Gong; Yu Ding; Feng Liang; Shuang Wu; Xiruo Tang; Hongzhang Ding; Wenjing Huang; Xiaotong Yu; Likun Zhou; Jun Li; Shaowen Liu
Journal:  Front Cardiovasc Med       Date:  2022-09-15

Review 5.  Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis.

Authors:  Wan-Li Cheng; Shao-Jung Li; Ting-I Lee; Ting-Wei Lee; Cheng-Chih Chung; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Biomedicines       Date:  2021-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.